Function of ssDNA aptamer and aptamer pool against Mycobacterium tuberculosis in a mouse model

Chen,Fan; Zhou,Jing; Huang,Yong-Hao; Huang,Feng-Ying; Liu,Qiang; Fang,Zhigang; Yang,Sheng; Xiong,Min; Lin,Ying-Ying; Tan,Guang-Hong

doi:10.3892/mmr.2012.1229

Function of ssDNA aptamer and aptamer pool against Mycobacterium tuberculosis in a mouse model

Authors:
- Fan Chen
- Jing Zhou
- Yong-Hao Huang
- Feng-Ying Huang
- Qiang Liu
- Zhigang Fang
- Sheng Yang
- Min Xiong
- Ying-Ying Lin
- Guang-Hong Tan
View Affiliations

Affiliations: Faculty of Life Sciences, Hubei University, Wuchang, Wuhan 430062, P.R. China, Wuhan Tuberculosis Dispensary, Qiaokou, Wuhan 430030, P.R. China, Hainan Provincial Key Laboratory of Tropical Medicine, Pharmacy School, Hainan Medical College, Haikou 571199, P.R. China, Hainan Provincial Key Laboratory of Tropical Medicine, Pharmacy School, Hainan Medical College, Haikou 571199, P.R. China
Published online on: December 12, 2012 https://doi.org/10.3892/mmr.2012.1229
Pages: 669-673

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Novel antibacterial agents against Mycobacterium tuberculosis (MTB) are crucial due to the high infection and mortality rates associated with the disease. Our previous study confirmed that aptamers from a whole bacterium obtained by the Systematic Evolution of Ligands by Exponential Enrichment method specifically bound to the MTB virulent strain (H37Rv). In the present study, the function of aptamers against MTB in a mouse model was further determined. It was demonstrated that the NK2 aptamer has marked inhibitory effects on the adhesion/invasion of H37Rv to macrophages in vitro and stimulates intracellular IFN-γ production in CD4+ T-cells. The aptamer pool exhibited the strongest inhibitory effect on H37Rv adhesion/invasion to CD8+ T-cells in vitro compared with all aptamers-treated and control groups. Histopathological examination of lung biopsy specimens revealed a correlation between aptamer presence and lower pulmonary alveoli fusion, swelling and more prominent air spaces. Acid-fast staining of biopsy specimens from the lungs of the mice demonstrated parallel treatment effects. Results of the present study indicate that the 10th pool aptamers and NK2 may play an active role against H37Rv, however, the effect was different in vivo and in vitro. The treatment effect of 10th pool aptamers was found to be better in comparison to NK2 in vivo. Additional target sites involved in pathogenicity of H37Rv were also revealed and the NK2 binding site and aptamers, including the 10th pool aptamers, may antagonize these sites. Further studies are required to screen for other valuable aptamers which may be used as therapeutic drugs in combination with NK2.

View Figures

View References

1	Raviglione MC, Dye C, Schmidt S and Kochi A: Assessment of worldwide tuberculosis control. WHO global surveillance and monitoring project. Lancet. 350:624–649. 1997. View Article : Google Scholar : PubMed/NCBI
2	Dye C, Scheele S, Dolin P, Pathania V and Raviglione MC: Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country WHO Global Surveillance and Monitoring Project. JAMA. 282:677–686. 1999. View Article : Google Scholar : PubMed/NCBI
3	Fine PE: Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 346:1339–1345. 1995. View Article : Google Scholar : PubMed/NCBI
4	Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Cohn DL, Lambregts-van Weezenbeek CS, Kim SJ, Chaulet P and Nunn P: Global surveillance for antituberculosis-drug resistance 1994–1997. World Health Organization-International Union against tuberculosis and lung disease working group on anti-tuberculosis drug resistance surveillance. N Engl J Med. 338:1641–1649. 1998.
5	Ahmed N and Hasnain SE: Genomics of Mycobacterium tuberculosis: old threats and new trends. Indian J Med Res. 120:207–212. 2004.
6	Baptista IMFD, Oelemann MC, Opromolla DVA and Suffys PA: Drug resistance and genotypes of strains of Mycobacterium tuberculosis isolated from human immunodeficiency virus-infected and non-infected tuberculosis patients in Bauru, São Paulo, Brazil. Mem Inst Oswaldo Cruz. 97:1147–1152. 2002.PubMed/NCBI
7	Pereira M, Tripathy S, Inamdar V, Ramesh K, Bhavsar M, Date A, Iyyer R, Acchammachary A, Mehendale S and Risbud A: Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian J Med Res. 121:235–239. 2005.PubMed/NCBI
8	Yew WW and Leung CC: Update in tuberculosis 2007. Am J Respir Crit Care Med. 177:479–485. 2008. View Article : Google Scholar : PubMed/NCBI
9	Jayasena SD: Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clin Chem. 45:1628–1650. 1999.PubMed/NCBI
10	Guthrie JW, Hamula CLA, Zhang H and Le XC: Assays for cytokines using aptamers. Methods. 38:324–330. 2006. View Article : Google Scholar : PubMed/NCBI
11	Ulrich H, Alves MJM and Colli W: RNA and DNA aptamers as potential tools to prevent cell adhesion in disease. Braz J Med Bio. 34:295–300. 2001. View Article : Google Scholar : PubMed/NCBI
12	Marimuthu C, Tang TH, Tominaga J, Tan SC and Gopinath SC: Single-stranded DNA (ssDNA) production in DNA aptamer generation. Analyst. 137:1307–1315. 2012. View Article : Google Scholar : PubMed/NCBI
13	Shimada T, Fujita N, Maeda M and Ishihama A: Systematic search for the Cra-binding promoters using genomic SELEX system. Genes Cells. 10:907–918. 2005. View Article : Google Scholar : PubMed/NCBI
14	Jensen KB, Atkinson BL, Willis MC, Koch TD and Gold L: Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. Proc Natl Acad Sci USA. 92:12220–12224. 1995. View Article : Google Scholar : PubMed/NCBI
15	Chen F, Zhou J, Luo F, Mohammed AB and Zhang ZL: Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. Biochem Biophys Res Commun. 357:743–748. 2007. View Article : Google Scholar : PubMed/NCBI
16	Chen F, Zhang XL, Zhou J, Liu S and Liu J: Aptamer inhibits Mycobacterium tuberculosis (H37Rv) invasion of macrophage. Mol Biol Rep. 39:2157–2162. 2012.PubMed/NCBI
17	Jagannath C, Emanuele MH and Hunter RL: Activity of poloxamer CRL-1072 against drug-sensitive and resistant strains of Mycobacterium tuberculosis in macrophages and in mice. Intern J Anti Agent. 15:55–63. 2000. View Article : Google Scholar : PubMed/NCBI
18	Jing N and Hogan ME: Structure-activity of tetrad-forming oligonucleotides as a potent anti-HIV therapeutic drug. J Biol Chem. 273:34992–34999. 1998. View Article : Google Scholar : PubMed/NCBI
19	Blank M, Weinschenk T, Priemer M and Schluesener H: Systematic evolution of a DNA aptamer binding to the rat brain tumor microvessels: selective targeting of endothelial regulatory protein pigpen. J Biol Chem. 276:16464–16468. 2001. View Article : Google Scholar
20	Cerchia L, Ducongé F, Pestourie C, Boulay J, Aissouni Y, Gombert K, Tavitian B, de Franciscis V and Libri D: Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol. 3:e1232005. View Article : Google Scholar : PubMed/NCBI